Growing evidence supports the notion that heterozygous PD-related GBA variants affect multiple PD pathways [46] (shown in Figure 1) by reducing glucocerebrosidase (GCase) activity in the lysosome, leading to altered lipid metabolism, aggregation of a-synuclein (α-syn) and impaired neuronal transmission. This evidence concerns the gene GBA1 and Parkinson disease.